Skip to main content
AVECHO BIOTECHNOLOGY LIMITED logo

AVECHO BIOTECHNOLOGY LIMITED — Investor Relations & Filings

Ticker · AVE ISIN · AU0000047441 LEI · 529900FA9G9T82C2LV25 ASX Manufacturing
Open in API
Filings indexed 881 across all filing types
Latest filing 2009-05-28 Regulatory Filings
Country AU Australia
Listing ASX AVE

About AVECHO BIOTECHNOLOGY LIMITED

https://avecho.com.au/

Avecho Biotechnology Limited develops and commercializes human and animal health products using its proprietary drug delivery system, Tocopheryl Phosphate Mixture (TPM®). Derived from Vitamin E, TPM® is designed to enhance the solubility and absorption of active ingredients through the skin and digestive tract. The company focuses on applying this technology to pharmaceuticals, nutraceuticals, and animal health sectors. A primary area of development includes medicinal cannabis, where Avecho has produced high-bioavailability cannabidiol (CBD) softgel capsules for therapeutic use. The company’s portfolio also includes applications in pain management and dermatology, leveraging TPM® to improve the delivery of poorly soluble molecules and enhance the efficacy of existing treatments.

Recent filings

Filing Released Lang Actions
Completion - Transdermal Patch Prototypes - Oxycodone 2 pages ?Kb
Regulatory Filings Classification · 95% confidence The document is a company announcement dated 29 May 2009 from Phosphagenics Limited. It discusses the completion of preclinical studies for a transdermal patch prototype delivering oxycodone. The content focuses on product development and preclinical study results, not on financial performance, regulatory filings, or shareholder matters. It is a press release announcing a scientific and commercial milestone rather than a financial report, regulatory filing, or management update. The document length is 5718 characters, which is relatively short and typical for a press release. There is no indication of financial data, earnings, management changes, or voting results. Therefore, the best fitting category is Regulatory Filings (RNS) as a general announcement that does not fit other specific categories.
2009-05-28 English
Chairman`s and COO`s Address to Shareholders 32 pages ?Kb
AGM Information Classification · 95% confidence The document is dated 29 May 2009 and is addressed to the ASX Limited Manager Company Announcements Office, indicating it is a formal company communication. The content includes the Chairman's and Chief Operating Officer's addresses, discussing the company's strategic decisions, financial position, product pipeline, and outlook. The document explicitly mentions it is related to the Annual General Meeting (AGM) and contains speeches and presentations typically delivered at such meetings. There is no detailed financial statement or comprehensive annual report data, but rather a narrative and presentation style consistent with AGM materials. The presence of slides and detailed strategic discussion further supports this classification. Therefore, this document fits the category of AGM Information (AGM-R).
2009-05-28 English
Results of Annual General Meeting 2 pages ?Kb
Declaration of Voting Results & Voting Rights Announcements Classification · 100% confidence The document is a communication from Phosphagenics Limited to the ASX Limited Manager Company Announcements Office dated 29 May 2009. It reports the results of resolutions passed at the Annual General Meeting (AGM) held on the same day. The resolutions include adoption of the Remuneration Report and election/re-election of directors. The document includes a detailed summary of voting results by proxy and show of hands. The content is focused on announcing the official voting results of the AGM resolutions, not the AGM materials themselves or the full annual report. The document length is short (2219 characters) and it explicitly states it is the result of voting at the AGM. Therefore, this fits the category of Declaration of Voting Results & Voting Rights Announcements (DVA).
2009-05-28 English
Bio International Convention Presentation - Atlanta, Georgia 24 pages ?Kb
Investor Presentation Classification · 100% confidence The document is a detailed slide presentation given by Phosphagenics Limited at the BIO International Convention in May 2009. It includes corporate overview, technology description, product pipeline, clinical trial status, regulatory filings, and business strategy. The content is structured as a presentation with slides and speaker notes, focusing on company technology and development programs. There is no indication that this is an annual report, earnings release, or regulatory filing. The document is not a transcript of a call, nor is it a voting result or management change announcement. It is clearly a presentation intended for investors and stakeholders to communicate company strategy and progress. Therefore, the document fits the category of Investor Presentation (IP). The document length is substantial (over 14,000 characters), consistent with a full presentation rather than a brief announcement or summary.
2009-05-20 English
Retinoic Acid - Two-staged Phase 1 Clinical Trial 4 pages ?Kb
Regulatory Filings Classification · 90% confidence The document is a company announcement dated 30 April 2009 from Phosphagenics Limited. It details the results of a Phase 1 clinical trial demonstrating increased delivery and reduced irritation of retinoic acid using the company's TPM platform technology. The content focuses on clinical trial results, product efficacy, and scientific data rather than financial performance, regulatory filings, or management changes. There is no indication that this is a financial report, regulatory filing, or management announcement. The document is a press release announcing clinical trial results, which fits best under the category of a general company announcement or regulatory filing. Since there is no specific category for clinical trial announcements, and it does not fit other categories like Earnings Release, Annual Report, or Investor Presentation, the best fit is Regulatory Filings (RNS) as a fallback category for miscellaneous company announcements that do not fit other specific categories.
2009-04-29 English
Annual Report-AGM documentation - Option Expiry Notice 89 pages ?Kb
Regulatory Filings
2009-04-13 English

Browse filings by year

23 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.